Founder & CEO
Dr. Andrew Chadeayne is the Founder and CEO of CaaMTech. Prior to founding CaaMTech, Andrew served as Chief Innovations Officer at ebbu, Inc. where he managed all aspects of the company’s patent strategy leading up to its sale to Canopy Growth Corporation in 2018. Over the past 20 years, Andrew has worked in virtually every area of chemical innovation, including Director of Intellectual Property for NewMarket Pharmaceuticals; patent agent at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; inventor at SwimSpray, LLC; and managing member of Chadeayne LLC, a patent prosecution firm. Andrew earned a BA in Chemistry from Princeton, a PhD in Chemistry from Cornell, and a JD from the George Washington University Law School.
Technology & Marketing
Davis Wuolle leads CaaMTech’s technology and marketing functions. His expertise lies in finding technological solutions to a diverse range of problems, from complex scientific research to digital marketing. Davis has over fifteen years of experience working with technology startups in Canada and the United States.
Jon Cooper brings a wealth of entrepreneurial and business experience to CaaMTech’s Board of Directors. He founded ebbu, a Denver cannabis company in 2013. Jon led ebbu to an acquisition by Canopy Growth Corporation (NYSE: CGC) in 2018, a deal worth C$429 million and went on to serve as Deputy Managing Director, US Operations and Expansion at Canopy Growth.
Board of Advisors